Your browser doesn't support javascript.
Anti-membrane Antibodies Persist at Least One Year and Discriminate Between Past Coronavirus Disease 2019 Infection and Vaccination.
Amjadi, Maya F; Adyniec, Ryan R; Gupta, Srishti; Bashar, S Janna; Mergaert, Aisha M; Braun, Katarina M; Moreno, Gage K; O'Connor, David H; Friedrich, Thomas C; Safdar, Nasia; McCoy, Sara S; Shelef, Miriam A.
  • Amjadi MF; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Adyniec RR; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Gupta S; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Bashar SJ; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Mergaert AM; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Braun KM; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Moreno GK; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • O'Connor DH; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Friedrich TC; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Safdar N; Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • McCoy SS; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Shelef MA; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Infect Dis ; 226(11): 1897-1902, 2022 Nov 28.
Article in English | MEDLINE | ID: covidwho-2135321
ABSTRACT

BACKGROUND:

The consequences of past coronavirus disease 2019 (COVID-19) infection for personal and population health are emerging, but accurately identifying distant infection is a challenge. Anti-spike antibodies rise after both vaccination and infection and anti-nucleocapsid antibodies rapidly decline.

METHODS:

We evaluated anti-membrane antibodies in COVID-19 naive, vaccinated, and convalescent subjects to determine if they persist and accurately detect distant infection.

RESULTS:

We found that anti-membrane antibodies persist for at least 1 year and are a sensitive and specific marker of past COVID-19 infection.

CONCLUSIONS:

Thus, anti-membrane and anti-spike antibodies together can differentiate between COVID-19 convalescent, vaccinated, and naive states to advance public health and research.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Experimental Studies Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Experimental Studies Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: J Infect Dis Year: 2022 Document Type: Article Affiliation country: Infdis